Pathogenesis and Clinical Presentation of Throat Candidiasis in Durrës area, Albania
Poster Mar 17, 2015
PhD Cand. Anisa Liti, Prof. Dr. Margarita Hysko
Candidiasis, commonly called yeast infection or thrush, is a fungal infection of any of the Candida spp., of which Candida albicans is probably the most common. In most individuals, C. albicans is a member of the normal human microbiome, resides as a lifelong, harmless commensal. Under certain circumstances, however, C. albicans can cause infections that range from superficial infections of the skin to life-threatening systemic infections. C. albicans is able to switch reversibly between yeast and hyphal growth forms in response to environmental cues. In this study, 1317 throat sampes were examined. These samples were recived by the Microbiology Laboratory of DRSH, Durrës, Albania, collected between April 2012 and December 2013.
We focused our attention on the prevalence of C. albicans in throat and it’s relation to sex, seasons and age.
It resulted that 372 out of 1317 samples were infected by C. albicans throat infections.
The infection was mostly prevalent in women, 63% out of all positive results.
The age group most affected were 76-90 years old and 46-60 years old.
We found this infection highly prevalent in autumn with 26% of positive results.
The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that regulate the expression of phase I (cytochrome P450s), phase II metabolizing enzymes and transporter genes in response to xenobiotics, including prescription drugs.READ MORE
RNA interference (RNAi) using small interfering RNAs (siRNAs) is an important technology for down-regulation of gene expression and a powerful tool to study cellular processes and pathways. Previously, large collections of siRNAs were available only for traditional experimental model systems, such as human and mouse, and predominantly provided as chemically synthesized libraries.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019